Clinical Trial Update: Injectable Buprenorphine in Prison: a Preference Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing injectable buprenorphine for opioid use disorder in incarcerated individuals. The trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Injectable Buprenorphine (buprenorphine)
• SUBLOCADE (buprenorphine extended-release)

Snippet

Sponsor: Lifespan | Conditions: Opioid Use Disorder, Incarceration | Phase 4 | Status: NOT_YET_RECRUITING